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Post-natal cardiomyocytes can generate iPS cells
with an enhanced capacity toward cardiomyogenic
re-differentation
R Rizzi1,2, E Di Pasquale2,3, P Portararo2, R Papait2,3, P Cattaneo2,3, MVG Latronico2, C Altomare4, L Sala4, A Zaza4, E Hirsch5,
L Naldini6, G Condorelli*,7,8 and C Bearzi1,2
Adult mammalian cells can be reprogrammed to a pluripotent state by forcing the expression of a few embryonic transcription
factors. The resulting induced pluripotent stem (iPS) cells can differentiate into cells of all three germ layers. It is well known that
post-natal cardiomyocytes (CMs) lack the capacity to proliferate. Here, we report that neonatal CMs can be reprogrammed to
generate iPS cells that express embryonic-specific markers and feature gene-expression profiles similar to those of mouse
embryonic stem (mES) cell and cardiac fibroblast (CF)-derived iPS cell populations. CM-derived iPS cells are able to generate
chimeric mice and, moreover, re-differentiate toward CMs more efficiently then either CF-derived iPS cells or mES cells.
The increased differentiation capacity is possibly related to CM-derived iPS cells retaining an epigenetic memory of the
phenotype of their founder cell. CM-derived iPS cells may thus lead to new information on differentiation processes underlying
cardiac differentiation and proliferation.
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Cell-based therapies constitute a promising therapeutic
option for many pathologies. Unfortunately, the development
of this approach for improving cardiac function in heart failure
is hindered by the difficulty in obtaining a reliable source of
functional cardiomyocytes (CMs). In fact, adult CMs are
characterized by a very low proliferation rate, and this limits
their use for replacement therapy.1 As a consequence, many
cell types have been tested for their potential as a source of
CMs.2 These have included mesenchymal and hematopoietic
stem cells, skeletal myoblasts, endothelial progenitors, and
resident cardiac stem cells.3 However, the use of these cells
as CM progenitors is controversial.
To date, embryonic stem (ES) cells constitute the only
reliable source of functional CMs. ES cells derive from the
blastocyst or early epiblast; when cultured in vitro, theymature
into so-called embryoid bodies (EBs), teratoma-like structures
that contain cells able to generate the three embryonic layers
(ectoderm, endoderm, and mesoderm).4 Human ES cells can
generate functional CMs with neonatal cell characteristics.5
However, the use of human ES cells is hampered by
difficulties in lineage generation from in vitro fertilized cells,
their immunogenicity – which is, nevertheless, lower com-
pared with that of adult cells – and above all by restrictions in
some countries on the generation of new embryonic cell
lines.6
Induced pluripotent stem (iPS) cells – genetically modified
cells generated by the integration of embryonic transcription
factor genes (Oct4, Sox2, Klf4, and c-Myc (OSKM)) into the
genome of adult somatic cells – may overcome some of the
above-mentioned difficulties related to the use of human ES
cells.7,8 iPS cells have been derived from various sources,
such as gastric epithelial cells, hepatocytes, embryonic
fibroblasts, adult tail-tip fibroblasts, pancreatic cells,
B lymphocytes, and neural stem cells from mouse, as well
as keratinocytes, skin fibroblasts, and peripheral blood cells
from humans.9 These cells form germ-line adult chimeras and
possess self-renewal and pluripotency characteristics that are
similar to ES cells.
In addition to their potential in cell-based therapies, iPS
cells may be used in the future for drug development and
testing in vitro, decreasing the necessity of in vivo toxicology
studies. iPS cells have already been generated from cells of
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patients with degenerative pathologies,10 opening up the
possibility of using patient-specific iPS cells to generate
study models of disease.
In the present study, we determined the ability of post-natal
CMs and cardiac fibroblasts (CFs) to act as a source of iPS
cells. Our results indicate that the genome of differentiated
cardiac cells can be reset to a pluripotent state. Moreover,
we found a genetic propensity in CM-derived iPS cells to
re-differentiate toward the fate of their founder cell.
Results
Primary culture of CMs and CFs and generation of iPS
cells with OSK factors. In an attempt to generate iPS cells
from CMs, we started by transducing primary CM cultures
with lentiviral vectors expressing four pluripotency factors
(OSKM) along with green fluorescent protein (GFP) as a
tracker. We found that CMs were capable of generating
clones with this procedure. However, the number of clones
produced was significantly less than that generated by CFs,
even though the transduction index was high in both cell
types (Supplementary Figure 1). We reasoned that this low
clonogenic efficiency could be due to the large expression
cassettes of the OSKM lentiviral vectors used, which contain
genes for an embryonic factor plus the GFP marker, limiting
the efficiency of transduction and, consequently, of the
reprogramming process. To overcome this problem, we
decided to transduce cells with vectors harboring bicistronic
constructs encoding Oct4 and either Sox2 or Klf4, without the
GFP gene (OSK lentiviral vectors) (Figure 1a).
In addition, we decided to improve another limit of our initial
procedure, that is, the purity of the CM population employed.
Even if the percentage of CF contamination was very low
with the culture methods used, we could not assume that the
clones derived from CM cultures were all generated from
CMs. Thus, in order to eliminate the chances of generating
iPS cells from contaminating CFs, we adopted a method
previously employed for monitoring the differentiation of
mouse ES (mES) cells into CMs:11 4 days before transduction
with OSK lentiviral vectors, primary cultures were incubated
with a cardiac-specific vector in which GFP expression is
driven by a short fragment of the cardiac troponin-I (TNNI3)
proximal promoter linked to a cardiac a-actin enhancer
(TNNI–GFP lentivirus vector). The brightest GFP-positive
cells were sorted and plated directly onto gelatin-coated
dishes, ready for incubation with OSK lentiviral vectors
(Supplementary Figure 2).
FACS analysis revealed thatE60% of cells originating from
CM cultures and only E0.9% of cells originating from
CF cultures expressed GFP after transduction with the
TNNI3–GFP lentivirus vector (Figure 1b, upper left panel;
Supplementary Figure 3 and related Supplementary Movie
S1). All these GFP-positive cells expressed a-sarcomeric
actin (a-SARC), indicating that they were CMs (Figure 1b,
upper right panel). The degree of purity of the sorted brightest
cells was confirmed by FACS and by quantitative Real Time
PCR (qRT-PCR) analyses of CM- and CF-specific markers
(Figures 1b, lower panels, and 1c).
Moreover, to exclude the possibility that progenitor cells or
immature CMswere contributing to any reprogramming taking
place, we tested for the expression of antigens and genes
that characterize developing cardiac cells. A contribution by
putative cardiac progenitors was ruled out by the absence of
c-kit-, isl1-, and Sca1-positivity in cells selected for TNNI3-
driven GFP expression (Figure 1d). In addition, the expres-
sion ofT-box transcription factor 5 (TBX5), beta-myosin heavy
chain (b-MHC), and NKX2.5 – genes expressed in immature
CMs – was either greatly reduced or zero in cells after the
sorting step (Figure 1e). In contrast, genes considered late,
such as alpha-myosin heavy chain (a-MHC) and TNNI, were
highly expressed after selection. As expected, GATA4 was
always expressed, and mES cells never expressed CM-
related genes.
We then used OSK lentiviral vectors to induce reprogram-
ming of cardiac cells. Compared with transduction with OSKM
constructs, reprogramming was significantly increased in both
compartments with the use of only OSK. Indeed, we counted
the number of colonies/plate expressing alkaline phosphatase
(ALP) – a hydrolase typical of the undifferentiated mES cell
state – 18 days after incubation with OSK lentiviral vectors
and found that the CM compartment became significantly
more prone to reprogramming than the CF one (Figure 2a;
Supplementary Figure 4). Moreover, 5-bromo-20-deoxyuri-
dine incorporation experiments conducted on GFP-expres-
sing CMs revealed that DNA synthesis increased after
transduction with OSK (Figure 2b). These results strongly
suggest that neonatal CMs transduced with the three
transcription genes proliferate while de-differentiating. Visual
confirmation attested that the clones from the CM compart-
ment spread much faster and become bigger than those
generated from CFs. With increased number of culture
passages, the morphology of CM- and CF-derived iPS cells
increasingly resembled that of ES cells (Figure 2c).
Molecular characterization of CM- and CF-derived iPS
cells. Immunofluorescence, colorimetric assay of ALP, and
molecular analyses were conducted at different time points
after OSK transduction. Twelve days after incubation with
OSK lentiviral vectors, we found that cells of CM- and
CF-derived colonies expressed stage-specific embryonic
antigen 1 (SSEA-1), an embryonic surface marker
(Figure 2d). In addition, cells were positive for ALP, and
endogenous octamer-binding transcription factor 4 (Oct4)
was found reactivated. These results further proved that
reprogramming was taking place.
Teratoma formation. We confirmed the pluripotency
of newly formed CM-derived iPS cells by the ability to form
teratomas when injected subcutaneously in NOD-scid mice.
Tumors were found in all these mice after 4 weeks.
Hematoxylin/eosin staining demonstrated the presence of
the three germ cell layers (Figure 2e). Moreover, the
karyotype did not present abnormalities and chromosome
conformation was considered normal (Figure 2f).
Generation of chimeras. We next investigated whether
CM-derived iPS cells were of a sufficient quality to produce
adult chimeras. Injection of CM-derived iPS cells generated
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Figure 1 CM- and CF-derived iPS cells obtained through transduction with OSK factors. (a) Maps of the two bicistronic OSK constructs used to improve the efficiency of clone
generation in CMs. LTR, long terminal repeats; Tk, thymidine kinase; SFFV, spleen focus-forming virus promoter; TaV, Thosea asigna virus 2A-like sequence; FMDV, foot-and-
mouth disease virus 2A-like sequence. (b) FACS analysis showing the percentage of GFP-positive cells in cultures of CFs and CMs after incubation with the TNNI3–GFP lentivirus
vector (upper left panel); scatter plot of a-SARC-expressing GFP-positive cells from a CM culture (upper right panel); FACS analysis on the brightest sorted CMs demonstrating the
purity of the population (lower right and left panels). a-SARC, alpha-sarcomeric actin; 1B10, fibroblast surface protein marker; PE, phycoerythrin; APC, allophycocyanin.
(c) Enrichment of the CM population demonstrated by qRT-PCR. CMs do not express the fibroblast marker prolyl 4-hydroxylase (P4Hb). An axis break has been introduced to
remove uninformative areas. CFM, starting cardiac population containing CMs and non-CMs; CM, sorted CM population. (d) Scatter plots of c-kit, Isl1, and Sca1 expression in
cardiac cells obtained from hearts at days 12.5 and 17.5 of gestation, 1 day after birth, and after TNNI-sorting. (e) qRT-PCR analysis of control mES cells and cardiac cells obtained
from hearts at days 12.5 and 17.5 of gestation, 1 day after birth, and after TNNI sorting
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from CD1 mice (white furred) into blastocysts of C57BL/6
mice (black furred) gave rise to newborn chimeras that
developed into adulthood and that showed coat-color
chimerism, indicating differentiation of iPS cells into
functional melanocytes (Figure 2g).
Expression of OSK factors and cardiac genes. qRT-PCR
was conducted to determine the temporal dynamics of gene
expression during de-differentiation in CMs transduced with
OSK. Suppression of the exogenous human embryonic
genes (Oct4, Sox2, and Klf4) and endogenous mouse
cardiac genes (TNNI, a-MHC) occurred at around day 30
post-transduction and was concurrent to re-expression of
endogenous mouse embryonic genes (Oct4, Nanog)
(Figure 2h). The cells had therefore been reprogrammed at
around this time and had reached a state of multipotency.
An increase in transcription of exogenous Oct4 and a
modest expression of a-MHC was noticed at day 18 of
reprogramming. According to a recent study, during the period
of de-differentiation there can be temporary expression of
exogenous Oct4, which inhibits the transcription of Sox2,
permitting subsequent mild activation of differentiation mar-
kers.12 However, as long as the expression of exogenous
Oct4 is transient, the reprogramming process progresses.
Global gene expression. Pearson’s correlation of the
global gene expression profiles obtained with DNA
microarrays revealed that CM- and CF-derived iPS cells
are clustered closely with mES cells (Figure 3a). Samples
obtained from each stem cell type always had an
inter-sample correlation of more than 0.90 (Supplementary
Figure 5).
When the threshold was set at a twofold change, 319 genes
resulted differentially expressed in CM-derived iPS cells
versus mES cells, whereas 381 genes were differentially
expressed in CF-derived iPS cells versus mES cells. Out of
these differences, only 172 overlapped in the two iPS cell
compartments (Figure 3b). These differences were reduced
to 87 genes when the threshold was set at a fivefold change
(Figure 3c). At this threshold, genes that were differently
upregulated in both iPS cell types versus mES cells included
actin-binding protein MIPP and Brachyury. Other genes were
upregulated more in CM-derived iPS cells than in CF-derived
iPS cells, such as insulin-like growth factor binding protein 5
(Igfbp5), C1q tumor necrosis factor related protein
2 (C1QTNF2), and aldehyde dehydrogenase family 3,
subfamily A1 (Aldh3a1).
Gene ontology (GO) annotation of the iPS cell-source-
dependent differentially expressed genes (DEG) list. We
hypothesized that some of the iPS cell-source-dependent
DEGs would be involved in molecular pathways important for
differentiation in CMs. In order to identify which types of
global cellular processes or specific molecular functions were
responsible for the propensity of CM-derived iPS cells to
become CMs, the DEG list was first annotated using the GO
database. Out of the genes found differentially expressed
with the twofold-change threshold, 463 genes were assigned
to biological process, cellular component, and molecular
function categories. The highest percentages of genes in the
biological process domain regarded cellular process,
biological regulation, and regulation of biological process
(Figure 3d, upper pie chart); in the molecular function
domain, the highest numbers of genes were part of
binding, catalytic activity, and molecular transducer activity
(Figure 3d, middle pie chart); in the cellular component
domain, cell, cell part, and organelle had the most hits
(Figure 3d, lower pie chart). These data confirm that CM- and
CF-derived iPS cells are similar, but not identical, to each
other and to mES cells.
Expression profile of genes involved in cardiovascular
and stemness pathways. The genes found significantly
differentially expressed were then grouped in relationship to
various pathways involved in cardiac development and
stemness using the GeneSifter software (PerkinElmer,
Seattle, WA, USA); results were classified according to the
terminology given by this software (Supplementary Figure 6).
For the smooth muscle cell (SMC) differentiation pathway, we
found that although there were no significant differences
among the three stem cell types, CM-derived iPS cells tended
to cluster with CF-derived iPS cells; in contrast, CM-derived
iPS cells clustered with mES cells for genes related to
endothelial cell (EC) differentiation (Figure 4, upper-left
panels). The genes that we found significantly upregulated
in CM-derived iPS cells were wingless-related MMTV
integration site 7 (Wnt7a), transcriptional co-activator with
PDZ-binding motif (TAZ), and low-density lipoprotein receptor-
related protein 6 (Lrp6), which was significantly upregulated in
CF-derived iPS cells as well (Figure 4, histograms).
Cardiogenic potential of CM- and CF-derived iPS cells
in vitro. Once the de-differentiation process was proven to
take place, we sought to determine whether it was possible to
differentiate CM- and CF-derived iPS cells into CMs. To this
end, we studied mouse embryonic fibroblast (MEF)-derived
Figure 2 Characterization of CM- and CF-derived iPS colonies. (a) Number of iPS colonies/35mm-dish formed on MEFs after 15 days from transduction of CMs and CFs
with OSK reprogramming factors. *Po0.005: t-test (N¼ 5 experiments for each clone). (b) Proliferation of post-natal CMs before and after transduction with OSK factors
(left panel). BrdU labeling in a colony 15 days after sorting (right panel). Scale bar represents 200mm. *Po0.005: t-test (N¼ 5 experiments for each clone). (c) Morphology of
CM- and CF-derived cells after 15 days from reprogramming (upper and lower left panels). Morphology of CM- and CF-derived iPS colonies at passages 2 and 20 (upper and
lower right panels). Scale bars represent 200mm. (d) Example of a 12-day-old CM-derived iPS clone stained for SSEA-1 (upper left panel); ALP expression in neonatal
CM-derived iPS cells 15 days after transduction with OSK vectors (upper right panel); Oct4 and DAPI staining (lower right and left panels, respectively) in a colony formed from
CMs. Scale bars represent 200mm. (e) Teratoma formation 4 weeks after injection of CM-derived iPS cells in NOD-scid mice. Hematoxylin/eosin-stained sections
demonstrating the presence of all three germ layers. (f) Normal karyotype of neonatal CM-derived iPS cells. (g) Two-week-old chimeric mouse, derived from a C57BL/6
blastocyst injected with CM-derived iPS cells obtained from a white CD-1 mouse, between two C57BL/6 wild-type littermates. CM-derived iPS cells are responsible for the
agouti coat color. (h) qRT-PCR analysis of embryonic- and cardiac-marker genes in mES cells and CMs transduced with OSK factors (N¼ 5 experiments for each clone)
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iPS cells along with mES cells and CM- and CF-derived iPS
cells, and exposed EBs grown from these cells to bone
morphogenetic protein 2 (BMP2), according to published
procedures.13 After 3 days, EBs were collected and stained
for Flk-1, an embryonic-stage cardiomyogenic-lineage
precursor marker.14 We found that Flk-1 positivity was
Figure 3 Genesifter analysis of changes in gene expression in mES cells and CM- and CF-derived iPS cells. (a) Comparisons of global gene expression in mES cells and
CM-derived iPS cells (left panel), mES cells and CF-derived iPS cells (middle panel), and CM- and CF-derived iPS cells (right panel). (b) Venn diagram of the number of genes
differentially expressed in CM- and CF-derived iPS cells and mES cells when a twofold change was taken as the threshold value. 381 genes were differently expressed
between mES and CF-derived iPS cells, whereas 319 genes were differently expressed between mES and CM-derived iPS cells; 172 of these genes were differently
expressed in both data sets (N¼ 3 experiments for each clone). (c) GeneSifter program heat map analysis of Illumina mouse gene array data from mES cells and CM- and
CF-derived iPS cells: 87 genes were found to be significantly differentially expressed in CM- and CF-derived iPS cells compared with mES cells when a fivefold change was
taken as the threshold value (N¼ 3 experiments for each clone). (d) GO annotations of genes found differentially expressed at the twofold-change threshold. The domains are
biological process (upper chart), cellular component (middle chart), and molecular function (lower chart) (N¼ 3 experiments for each clone)
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present at this time in several clones originating from
CM- (Figure 5a, left panel) or CF-derived iPS cells exposed
to BMP2. FACS analysis performed at early time points of
differentiation showed that CM-derived iPS cells started to
express Flk-1 before the other cell types tested (Figure 5b).
Positivity for c-kit, which is expressed in putative cardiac
progenitor cells,15 was not encountered (Figure 5a, right
panel).
Western blotting was then carried out for cardiac markers to
obtain proof of CM differentiation from iPS cells.We found that
a-SARC, TNNI, myosin light chain 2V (MLC 2V), and NKX2.5
were expressed in cells upon exposure to BMP2 (Figure 5c).
MLC 2A – the atrial MLC isoform – was not expressed,
indicating that cells were more frequently differentiating
toward the ventricular lineage.
Beating areas started to appear 6 days after BMP2
exposure (Supplementary Movies S2 and S3). The number
of these beating areas was greater in cultures originating from
CM-derived iPS cells (Figure 5d). The greater propensity of
CM-derived iPS cells to become CMs compared with CF- and
MEF-derived iPS cells and mES cells was established
by qRT-PCR analysis conducted at different time points.
The appearance of early CM markers, such as Brachyury,
Mef2c, and Tbx5 (Figure 5e, upper panels), became evident
earlier in CM-derived iPS cells than the other cell types. The
expression of mature myocardial genes, such as a-MHC and
TNNI, was higher in CM-derived iPS cells at the later stages of
differentiation (Figure 5e, lower panels).
In addition, both cardiac-derived iPS lines could differenti-
ate into three lineages found in the myocardium: CMs, ECs,
Figure 4 Cardiovascular and stemness pathways in CM- and CF-derived iPS cells. Heat maps (upper-left panels) and histograms of the genes found to be significantly
up- or downregulated in different cardiovascular- and stem-cell-related pathways. The classification shown is that generated by GeneSifter. *Po0.05 versus mES, ANOVA
(±S.E.M.). Gene expression by DNA microarray, analysis by GeneSifter software (N¼ 3 experiments for each clone)
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Figure 5 Cardiac lineage differentiation of CM- and CF-derived iPS cells in vitro. (a) Immunofluorescence for Flk-1 on an EB 4 days after exposure to BMP2, attesting
in vitro differentiation into CM precursors (left panel). The lack of a signal for c-kit demonstrates the absence of putative cardiac progenitor cells that might have been
responsible for the cardiogenic differentiation observed (right panel). Scale bars represent 100mm. (b) Flow cytometry plots for Flk-1 expression at 0, 5, and 12 h after
exposure to BMP2 in mES and CM- and CF-derived iPS cells. (c) Representative western blot of cardiac markers in differentiated and undifferentiated CF- and CM-derived
iPS cells. Ventricular and atrial cells were used as positive controls. To remove uninformative areas, the panel has been cropped. (d) Number of beating areas in cultures
derived from mES cells, CM- and CF-derived iPS cells, and MEF-iPS cells, 6, 7, and 8 days after exposure to BMP2. *Po0.001: t-test (N¼ 4 experiments for each clone).
(e) qRT-PCR analysis of early and late cardiac marker genes in mES cells and CM-, CF-, and MEF-derived iPS cells at different time points after transduction of cells with
OSK transcription factors. An axis break has been introduced to remove uninformative areas (N¼ 5 experiments for each clone)
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and SMCs (Figure 6a). However, CM-derived iPS cells
differentiated into CMs more often than into SMCs or ECs.
In fact, the number of cells expressing a-MHC and a-SARC
was significantly greater in those originating from CM-derived
iPS cells (Figure 6b).
Ca2þ response in CM- and CF-derived iPS cells after
BMP2 exposure. Functional differences in commitment
toward the cardiac phenotype was tested by comparing
stimulus-induced Ca2þ release in differentiated CM- and
CF-derived iPS cells and neonatal CMs, used as a reference
(Figure 7). Responsiveness to caffeine,16 which acts on
muscle-specific ryanodine receptor channels, was
significantly higher in differentiated CM-derived iPS cells
than in differentiated CF-derived iPS cells. Responsiveness
to nicotine, acting on the nicotinic acetylcholine receptor
(nAChR), was negligible in all cell types, and this ruled out
differentiation toward skeletal muscle. Responsiveness to
ATP and acetylcholine (ACh), mediated by inositol
trisphosphate (IP3) release in many cell types and well
represented in SMCs,17 was low in all cell types. The
combined unresponsiveness to nicotine and infrequent
response to IP3-mediated stimuli suggests that caffeine
responsiveness was largely indicative of cardiac
differentiation.
Discussion
In this report, we demonstrate that two myocardial cell types
can be reprogrammed to generate iPS cells and that both can
produce new cardiovascular cell populations in vitro, albeit
with different efficiencies. In particular, we show for the first
time that CMs are capable of generating iPS cells, and that
when we used only OSK for the reprogramming of cardiac
cells, the CM compartment, remarkably, was significantly
more efficient in generating iPS cells than was the CF one. As
post-natal CMs lose their proliferative capacity soon after
birth, they possess a limited ability to survive and undergo cell
replication in culture. In fact, CMs have a proliferation index
that peaks atB10% on neonatal day 4.6 and declines rapidly
to zero thereafter,18 and can only be forced to re-enter the cell
cycle by transfecting cell-cycle regulatory genes or by
exposure to growth factors.19 Therefore, it is conceivable that
CM-derived iPS cells were formed from the residual number of
CMs still actively cycling immediately after birth. Why CMs are
better at producing iPS cells than CFs with the OSK protocol
needs further investigation.
In addition, we show that CM-derived iPS cells are better at
differentiating into functional CMs after exposure to BMP2
than are CF-derived iPS cells or mES cells, or MEF-derived
iPS cells. In fact, CM-derived iPS cells generated more
a-MHC- and a-SARC-positive cells and beating areas per dish
after the cardiac differentiation procedure than did the other
stem cell types. BMP2, a transforming growth factor b (TGF-b)
family member that is expressed in lateral endoderm and
ectoderm, has an important role in cardiac development in
vertebrate embryos.20 Expression of cardiac-specific proteins
by TGF-b is mediated by GATA4 and NKX2.5,21 and this
factor was found to be upregulated more than threefold
in CM-derived iPS cells compared with mES cells and
CF-derived iPS cells when the threshold was set at a twofold
change.
We also found that although CM- and CF-derived iPS cells
are comparable to mES cells in the expression of transcription
factors (e.g., endogenous Oct4) and surface markers for
pluripotency (e.g., SSEA-1), they did show architecture-
specific variations in their gene expression profiles, which
may probably explain the differences in the yield of CMs
following the induction of cardiogenic differentiation. Indeed,
microarray analysis of global gene expression in iPS cells
derived from both cardiac compartments identified upregula-
tion of genes directly involved in cardiogenesis during the
early days of embryonic life, such as Brachyury and fibroblast
growth factor 2 (Fgf2). Brachyury facilitates BMP-induced
differentiation of human and mouse pluripotent stem cells,
and cooperates with Fgf2 (via ERK) in mesoderm rather than
endoderm.22
Igfbp5, C1QTNF2, and Aldh3a1 were also found upregu-
lated in iPS cells when the threshold was set at a twofold
change. Igfbp5, found in the precardiac region and early
cardiac crescent,23 encodes a member of the IGF-I-binding
protein family that bindswith high affinity to both IGF-I and IGF-
II.24 Igfbp5 expression is induced by treatment with IGF-I in
both aortic and vascular SMCs in a wortmannin- and
rapamycin-sensitive manner, suggesting that induction of
Igfbp5 is downstream of the PI3K/mTOR signaling pathway.25
Higher expression of Igfbp5 may indicate different epigenetic
imprinting in CM- and CF-derived iPS cells. Regarding
C1QTNF2, it was reported that this protein induces the
phosphorylation of AMPK in myocytes, resulting in increased
glycogen accumulation and fatty acid oxidation.26 On the other
hand, Aldh3a1 expression regulates proliferation, survival, as
well as cellular response to oxidative stress.27 It is thus
possible that this gene is implicated in CM differentiation.
Wnt7a is a highly upregulated gene in CM-derived iPS cells.
Wnt7a mRNA expression is present in the ventricles of
embryos,28 and Wnt and Wnt-related signal transduction
contributes to mesodermal specification during early cardio-
genesis and later cardiac development and maturation.29 It is
well known that the formation of mesoderm is dependent on
canonical Wnt signaling.30 In particular, Wnt/b-catenin signal-
ing uses Brachyury expression as a marker of activation.31
Thus, the upregulation of Wnt and Brachyury in CM-derived
iPS cells mimics the mechanism occurring in the early embryo
for mesoderm induction, a prerequisite for the formation of
cardiac progenitor cells.32
Another gene found highly upregulated in CM-derived iPS
cells with respect to mES cells is Lrp6. This gene regulates
specification, proliferation, and survival of cardiac progenitors
and the expression of multiple cardiogenic genes, including
Tcfap2a and Pax3, Isl1, Msx1/Msx2, Fgf8, and Mef2C during
cardiogenesis.33
The final gene found significantly upregulated in
CM-derived iPS cells is TAZ, which encodes for a WW
domain-containing cofactor. TAZ co-associates with TBX5
and histone acetyltransferase proteins and mediates TBX5-
dependent gene activation during cardiac development.34
TAZ also functions as a co-activator of GATA4, stimulating
GATA4 activity on the ANF promoter in several cell lines.
TAZ and GATA4 physically interact with each other thorough
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the N-terminal region of TAZ and activation domain of GATA4.
Moreover, the Notch signaling pathway may regulate the
activity of cardiac transcription factors, including GATA family
proteins, by inhibiting TAZ.34
All these differences between CM-derived iPS cells and the
other stem cell types investigated in our study strongly
suggest that CM-derived iPS cells retain an ‘epigenetic
memory’ of the cardiogenic fate of their originating cell type,
which can influence the outcome of subsequent differentia-
tion. On this point, it has been demonstrated that iPS cells
derived from human fibroblasts, adipose tissue, and kerati-
nocytes, and from granulocytes, muscle progenitors, fibro-
blasts, and lymphocytes35 show differences in gene
expression that are indicative of transcriptional memory. The
DNA methylation pattern of iPS clones has also been used to
predict the somatic cell from which they were derived.36
We have demonstrated as a proof of principle that CMs can
generate iPS cells. We believe that these cells have
significant investigative potential in the study of epigenetic
mechanisms and the genes underlying cell cycling and
cardiomyogenic differentiation processes.
Materials and Methods
Generation of lentiviral vectors. The lentiviral vector used to introduce a
GFP transgene under the influence of a cardiac-specific promoter for the
ultrapurification of CMs (TNNI3–GFP lentivirus vector), was produced as described
elsewhere.11 See Supplemental Experimental Procedures.
The lentiviral vectors employed for the induction of reprogramming via OSK
factors harbored bicistronic constructs expressing Oct4 and either Sox2 or Klf4
(OSK lentiviral vectors). These vectors, and those used for transducing all 4
Yamanaka factors (OSKM), were generated as described in Supplemental
Experimental Procedures and Supplementary Table 1.
Myocardial cell cultures. CMs and CFs were obtained from of 1-day-old
CD-1 mice (Charles River Laboratories, Wilmington, MA, USA) as previously
described.37 All animal procedures were performed in accordance with the Guide for
the Care and Use of Laboratory Animals and approved by the Institutional Animal Care
and Use Committee. CMs were seeded and kept overnight inmedium containing BrdU
to inhibit cell proliferation. See Supplemental Experimental Procedures.
Enrichment of the cardiomyocyte compartment. CMs and CFs were
incubated with the TNNI3–GFP lentiviral vector 3 days after isolation. CMs were
purified through cell sorting for GFP positivity 48 h after transduction. Sorted cells
were plated on gelatin and cultured in CM expansion medium, ready for the
reprogramming step.
Generation of iPS cells. To induce reprogramming, CMs and CFs were
exposed 3 days after sorting to a mixture of equal volumes of the two OSK lentiviral
vectors. Four days after transduction, cells were trypsinized and plated on a mouse
MEF-feeder layer (Millipore, Billerica, MA, USA ) at a density of 1.6 103 cells/cm2
and cultured in propagation medium composed of Knockout DMEM (Invitrogen,
Carlsbad, CA, USA) containing 15% KnockOut Serum Replacement (Invitrogen),
2 mM L-glutamine, 100mM NEAA (non-essential amino acids), 10 ng/ml bFGF
(Peprotech, Rocky Hill, NJ, USA), 500mM VPA (EMD Biosciences, San Diego, CA,
USA), 100mM b-mercaptoethanol (Invitrogen), 1000 U/ml LIF (Millipore), penicillin
(100 U/ml), and streptomycin (100mg/ml). Any iPS cells thus derived were
maintained on MEFs in complete medium containing bFGF, VPA, and LIF
(Supplementary Table 2).
Figure 6 Quantitative evaluation of different cardiac lineages in vitro. (a) Representative fluorescence images for alpha-sarcomeric actin (a-SARC) (red), von Willebrand
factor (vWF) (white), and smooth muscle actin (SMA) (green), demonstrating differentiation of CM-derived iPS cells toward CM, EC, and SMC lineages, 10 days after exposure
to BMP2. Nuclei were stained with DAPI (blue). The areas in the rectangles are shown at higher magnification. Scale bars represent 40 mm. (b) Flow cytometry plots showing
expression of a-MHC (alpha-heavy myosin chain), a-SARC, vWF, and SMA in mES cells and in CM- and CF-derived iPS cells, 10 days after BMP2 treatment (N¼ 4
experiments for each clone)
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Figure 7 Responsiveness to Ca2þ releasing stimuli specific for muscle (caffeine, acting on ryanodine receptor (RyR), and nicotine, acting on nAChR) or shared by
many cell types (ATP and Ach, acting through IP3). (a) Representative images of total cell pixels (in white, left panels) and caffeine activated pixels (F/F0 above threshold in
color scale, right panels) for each experimental group. NCM, neonatal CM, used as a control. (b) Statistics of the proportion of ‘cell pixels’ activated by the test intervention
in each experimental group (number of fields analyzed ¼ 7, 12, and 10 for CMs, differentiated CM- and CF-iPS cells, respectively). *Po0.05 versus CMs; #Po0.05 versus
differentiated CM-derived iPS cells
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Embryoid body formation and in vitro differentiation of iPS
cells. Undifferentiated CM- and CF-derived iPS cells were cultured in
propagation medium containing 2.5 ng/ml. BMP2 (Invitrogen) for 12 h. Cells were
then harvested by trypsinization, spun down for 5 min at 1000 r.p.m., and
resuspended in differentiation medium (DF medium) composed of DMEM, FBS,
L-glutamine, NEAA, penicillin, and streptomycin. Successively, iPS cells were
counted and diluted down to 25 000 cells/ml. The underside of bacterial dish lids
was then spotted with 60 drops containing 500 cells each. After 4 days of hanging-
drop culture, EBs were collected, seeded on gelatinized plates, and cultured in
DF medium. EBs began to show areas of spontaneous contraction on day 6. On the
forth day, some EBs were collected, fixed in 4% paraformaldehyde, and stained for
Flk-1; 10 days after BMP2 treatment, cells were fixed and stained for a-SARC in
order to identify any cells differentiated into CMs.
Chimera formation. iPS Cells deriving from CMs or CFs were aggregated
with zona-pellucida-free eight-cell stage embryos to generate chimeras as
described previously.38
Teratoma. formation. 5 105 cells/mouse were injected subcutaneously in
five NOD-scid mice. Tumors were sought after 4 weeks.
Gene expression profiling. Expression of endogenous and exogenous
genes was analyzed by RT-PCR (OSKM) and qRT-PCR (OSK) using standard
protocols (Supplementary Tables 3 and 4). See Supplemental Experimental
Procedures.
DNA microarray for whole-genome gene expression. BeadChip
Array MouseWG-6 v2 (Illumina, San Diego, CA, USA) was used for whole-genome
expression analysis following the protocol provided by Illumina. See Supplemental
Experimental Procedures.
Western blotting analyses, immunohistochemistry and
immunocytochemistry, and flow cytometry and cell
sorting. These procedures were performed following standard protocols. See
Supplemental Experimental Procedures.
Ca2þ response in CM- and CF-derived iPS cells after BMP2
exposure. Four days after BMP2 treatment, EBs were plated on glass coverslips
and incubated in DF medium. During the incubation period, cells migrated from the
EBs, forming an almost uniform cell layer. Freshly dissociated neonatal CMs were
similarly plated and kept for 1 day in CM medium.
At day 7, cells were loaded with the Ca2þ -sensitive dye Fluo4-AM (20 mM, 1 h at
37 1C). Images (512 512 pixels) were recorded (field size 441 441mm) with a
confocal microscope (Leica TCS-SP2, Leica, Wetzlar, Germany) at a sampling rate
of 1.2 Hz. The ratio between dye fluorescence over time and its value in basal
conditions (F/F0) was recorded. As cell boundaries were not visible in cell layers,
response to the test intervention was quantified by the proportion of pixels
corresponding to cell-covered areas (‘cell pixels’) in which F/F0 changed more than
a threshold value (‘active pixels’, Figure 7, right panels). The number ‘cell pixels’ was
counted in digital images (Figure 7, left panels), obtained by applying a F/F0
threshold to pixel values integrated over the recording period.
Cells were superfused with Ca2þ -free (0 mM Ca2þ þ 1mM EGTA) Tyrode’s
solution. Substances (10mM caffeine, 200mM ATP, 30mM ACh, or 100 mM
nicotine), diluted in the superfusate, were applied by a fast switch perfusion system.
Experiments were performed at 25±2 1C.
Statistics. All data are expressed as mean±S.E.M.. For cell studies, we
analyzed a total of four different clones per cell type. In some instances, data were
pooled from different cultures originating from each clone. Unpaired t-test or one-
way ANOVA was used, as appropriate, to assess statistical significance between
groups. A binomial distribution of values was assumed whenever ANOVA was
applied to categorical data (SPSS 19); Bonferroni correction was applied to
post-hoc comparisons. As the experimental unit is the cell and each cell is
represented by multiple pixels, considering pixel numbers would unduly increase the
analysis degrees of freedom; thus, to avoid overestimating significance, pixels were
binned by using a bin size approaching cell size (200 pixelsE150mm). Pearson’s
correlation was used to test the internal correlation between the samples and
between the groups involved in gene expression assay. No significant differences
were found in the data obtained from each clone of a specific cell type.
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